Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aberrant Lympahtic Drainage of Splenic Flexure Cancer: Are Splenic Hilar Nodes Metastases an Underecognized Phenomenon?

NCT04666883 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.

NCT NCT04666883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04666883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aberrant Lympahtic Drainage of Splenic Flexure Cancer: Are Splenic Hilar Nodes Metastases an Underecognized Phenomenon?
Lead sponsor
University of Rome Tor Vergata
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2021
Completion date
March 1, 2021
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, metastases, lymphatic